Theophylline metabolism in relation to antipyrine, debrisoquine, and sparteine metabolism

Rune Dahlqvist, Leif Bertilsson, Donald J. Birkett, Michel Eichelbaum, Juliette Sawe, Folke Sjöqvist

    Research output: Contribution to journalArticlepeer-review

    39 Citations (Scopus)


    Theophylline plasma clearance (Clp) and clearance to its metabolites (Clm) as well as antipyrine saliva clearance (Clsat) and its Clm were compared in a crossover study in 25 healthy subjects. They were selected with regard to smoking status (nine smokers, 16 nonsmokers) and oxidation phenotype of debrisoquine and sparteine (six poor metabolizers [PMs] and 19 extensive metabolizers [EMs]). Clm of theophylline (1,3-dimethyluric acid, l-methyluric acid, and 3-methylxanthine) correlated (r ≥ 0.92) to each other and to total theophylline Clp (r ≥ 0.97). Smokers had higher Clm to all metabolites, particularly by the N-demethylation pathways. After correction for the effect of smoking, there was no difference between EMs and PMs with regard to theophylline Clp or Clm Antipyrine clearances by EMs and PMs (Clsat and Clm of 4-OH-antipyrine, 3-OH-methylantipyrine, or norantipyrine) also did not differ. Antipyrine Clsat and Clm correlated to theophylline Clp (r between 0.50 and 0.69). It is concluded that theophylline metabolism (N-demethylations and C-oxidation) is not under the same genetic control as sparteine and debrisoquine oxidations, and that there may be a partial overlap in factors that regulate the metabolism of theophylline and antipyrine.

    Original languageEnglish
    Pages (from-to)815-821
    Number of pages7
    JournalClinical Pharmacology and Therapeutics
    Issue number6
    Publication statusPublished - Jun 1984


    Dive into the research topics of 'Theophylline metabolism in relation to antipyrine, debrisoquine, and sparteine metabolism'. Together they form a unique fingerprint.

    Cite this